FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist
Article in Cells (February 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Article in Cells (February 2024)
Book chapter (January 2024)
Article in Amino Acids (March 2022)